淋巴组织肿瘤PPT参考幻灯片_第1页
淋巴组织肿瘤PPT参考幻灯片_第2页
淋巴组织肿瘤PPT参考幻灯片_第3页
淋巴组织肿瘤PPT参考幻灯片_第4页
淋巴组织肿瘤PPT参考幻灯片_第5页
已阅读5页,还剩181页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

淋巴瘤Lymphoma基础医学院病理学系同济医院病理研究所敖启林,1,DrJohnK.C.CHAN陈国璋,2,4thEditionPublished20/9/2008,3,第一节概述一、定义“来源于”成熟淋巴细胞及其前体细胞(淋巴母细胞)的恶性肿瘤,分为非霍奇金/白血病和霍奇金淋巴瘤两大类。二、分类(一)非霍奇金淋巴瘤(NHL):包括B,T和NK细胞(70%)1、前体细胞:B/T/NK前体细胞(淋巴母细胞)淋巴瘤(2%)2、成熟细胞:成熟细胞淋巴瘤(68%)B细胞(54%)T细胞(12%)NK/T或NK细胞(2%),4,(二)霍奇金淋巴瘤(HL):特殊类型成熟B细胞淋巴瘤(30%)结节性淋巴细胞为主型(1.5%)经典型(28.5%)(缺陷性B细胞)结节硬化型淋巴细胞丰富型混合细胞型淋巴细胞消减型,5,第二节淋巴结的免疫结构(immunoarchitecture)一、概念:通过免疫组织化学染色显示淋巴结的结构特征。包括肿瘤性或非肿瘤性细胞的成分(淋巴细胞,辅助性非淋巴细胞,淋巴窦,血管,网状纤维等)、数量、分布方式等特征。通过对比,掌握正常和异常免疫结构,对淋巴结病变进行诊断和鉴别诊断。高质量的组织学切片和合理的免疫标记物的选择是识别免疫结构的关键。,6,二、淋巴结的正常免疫结构(一)淋巴结结构:皮质,髓质,窦,被膜和纤维小梁,7,(二)B淋巴细胞分布:1.主要在浅皮质区的初级和次级滤泡,髓索和副皮质区也含一定量B细胞;2.B细胞分化过程中的形态和免疫学特征成为非霍奇金B细胞淋巴瘤分类的基础。,8,9,10,PrepreBcell,PreBcell,ImmatureBcell,MatureBcell,ActivatedBcell,Plasmacell,Precursorcells;antigennon-responsive,VirginBcells;antigenresponsive,Germinalcenterantigenencountered,TdT,CD20,CD22,CD19,PAX5,CD79a,CD10,Bcl-6,CD138,CytoplasmicCD22,11,Immunoarchitectureofnormallymphnode,Bcells(CD20+,CD10+,BCL-6+),Tcells(CD3+);onlysmallnumbersofCD20+cells,12,13,1、初级滤泡:处女型B细胞和成熟小淋巴细胞;,14,CD20,2、次级滤泡:由生发中心、套区和边缘区构成。,15,Organizationofsecondarylymphoidfollicle,Marginalzonecells(IgM),Mantlezonecells(IgM+D),Folliclecentercells(IgM,IgG,IgAorIgE,notIgD),:约2:1,当:8-10:1或:3:1提示轻链限制表达,16,次级滤泡生发中心、套区和边缘区免疫标记:(1)生发中心(GerminalCenter,GC):1)中心细胞和中心母细胞:CD10+,BCL-6+,Bcl-2-,2)滤泡树突细胞(Folliculardendriticcells,FDC):CD21+,CD23+,CD35+3)T细胞:CD4+,CD10+,CXCL13/PD-1+,少量CD57+4)可染体巨噬细胞:CD68+,lysozyme+,CD11c+(2)套区:处女型B细胞和记忆细胞,表达IgM,IgD(3)边缘区:无特殊标记,绝大多数次级滤泡难以鉴别,腹腔淋巴结易识别。,17,CD20,18,CD79a,19,20,21,22,CD21,23,CD10,Bcl-6,24,反应性滤泡增生的特点对T细胞依赖性抗原的反应滤泡增多,大小、形态不等,可弥漫分布,主要位于皮质区,无背靠背现象。典型生发中心具有极性(Polarity):明区和暗区,套区明显,扁桃体组织更易识别;星天现象,中心细胞和中心母细胞混杂,免疫染色:生发中心细胞BCL-2-,ki-67指数较高。滤泡间区一般无B细胞弥漫阳性,B细胞CD43和CD5阴性。,25,26,27,Darkzone,Lightzone,28,BCL-2,Ki67,29,Marginalzonecells,30,CD20,31,(三)T淋巴细胞分布:副皮质区(paracortex),T淋巴细胞为主(CD4CD8):主为小淋巴细胞,偶尔出现大细胞(可以是活化的B细胞);含有高内皮静脉(Highendothelialvenules,HEV):血液淋巴细胞入淋巴结的通道;含有指状树突细胞(interdigitatingdendriticcells,IDC):S100+的专职抗原递呈细胞;,32,33,34,Prothymocyte,Subcapsularthymocyte,Corticalthymocyte,Medullarythymocyte,PeripheralTcell,Precursorcells,MatureTcells,Cytoplasmic,Surface,CD4,CD8,CD1,CD4,CD8,CD3,CD2,CD7,TdT,35,36,IDC,37,CD3,38,副皮质区增生,常见病因:病毒感染,接种疫苗,药物,自身免疫疾病,皮病性淋巴结炎,肿瘤转移等形态特征:副皮质扩大,可形成结节;HEV增生;混合小淋巴细胞和转化淋巴细胞,浆细胞,树突细胞,嗜酸性粒细胞等;免疫染色:主为T细胞,或T/B细胞混合,一般无B细胞为主弥漫分布。,39,40,41,Immunoblast,Infectiousmononucleosis,42,CD20,CD3,LargecellscomprisemixtureofBandTcells-Reactiveprocess,43,CD30+cellsarescatteredandstainingisweakormoderate,whichindicatestheheterogeneityofthelargecellpopulation.,CD30stainingisdiffuselystrongpositive,whichindicatesthemonocloneentity.,44,Kappa,Lambda,LargeBcellsarepolytypic,45,T细胞为主时支持良性的依据(谨慎!):(1)结构不同程度保留:淋巴窦和皮质淋巴滤泡;(2)大细胞群体分布不规则或呈地图样,不形成膨胀性团块;(3)无浸润现象:上皮,脂肪,血管,神经,纤维间质中单行排列;(4)细胞无明显异型:BLeukemia(ALL):BTUntreated:rapidlyfatalAggressivetherapy:goodsurvivalCannotpredictlineagefrommorphologyDefiningmarker:TdT+,CD99,78,79,80,CD20,CD79a,B-LBL,81,T-LBL,82,滤泡性淋巴瘤FOLLICULARLYMPHOMA,UsuallyinvolvinglymphnodesHigh-stagediseaseatpresentationPathology:RecapitulatestheorganizationandcytologyofthenormalgerminalcentersKeyimmunophenotype:Bmarker+,CD10+,Bcl6+,Bcl2+Follicularlymphomainvolvingsomeextranodalsites(suchasskin,duodenum,testis)showdistinctiveclinicalandbiologicfeaturesGenetics:Iggenerearrangement;t(14;18)(q32;q21)bcl-2generearrangement(duetoBCL2/IGHtranslocation),83,Follicularlymphomavsreactivefollicularhyperplasia,MajorcriterionCloselypackedfolliclesthroughout,withscantyinterfolliculartissues,1majorcriterionor3minorcriteria.Butconfirmbyancillarytestsifuncertain,84,滤泡性淋巴瘤主要诊断标准示意图,Majorcriterionfulfilledin80%ofcasesoffollicularlymphoma,Justgoontohighmagnificationtoconfirmfolliclecentercellmorphology,85,86,87,Centrocytesoftenhavetriangularshapednuclei,88,滤泡性淋巴瘤的次要诊断标准,Intheremaining20%ofcases(non-crowdedfollicles),acombinationofminorcriteria(3)havetobeconsidered,andsupplementedbyancillarystudiesasrequired,89,MinorcriteriaNotingible-bodymacrophagesCellularmonotony:centrocytepredominanceNocellularpolarisationAbsentorincompletemantlesFolliclesinperinodaltissuesDysplasticfollicularcentercells,e.g.signetringcells,frequentcytoplasmicglobulesAtypicalcellsininterfolliculartissuesInvasionofwallsofbloodvessels,90,91,92,93,94,FollicularlymphomavsRFH:ancillarytechniques,Immunostainingforbcl-2MostusefulimmunostainNormal:BothTandBcellspositiveexceptfolliclecentercellsLookforpositivestainingofcellsinfolliclecenters:positivestainingsupportsdiagnosisoflymphoma,95,Reactivefollicles,96,Follicularlymphoma(Bcl-2immunostaining),97,Commonmisconceptionsinhematopathology,Negativebcl-2stainrulesoutfollicularlymphomaThetruth:Itdoesnot.20-25%offollicularlymphomacasesarenegative.Pursuewithotherteststoconfirmorrefuteadiagnosisoffollicularlymphoma,98,Bcl-2staininginfollicularlymphoma,99,100,Bcl-2,101,LookforevidenceinterfollicularinvasionDenselypackedCD20+orCD79+B-cellsbetweenfolliclesisindicativeofinterfollicularinvasionPresenceofasignificantnumberofCD10+lymphoidcells(notneutrophils,whicharealsoCD10+)betweenfolliclesalsoindicatesinterfollicularinvasionLookforvascularinvasionManyCD10+cellsinthewallsofperinodalbloodvessels,102,CD20,103,CD10,104,105,LookformonoclonalityorlowproliferationindexImmunostainforIgtolookforlightchainrestrictionDemonstratedbyKi67,alowKi67indexfavorsdiagnosisoffollicularlymphomaoverRFH(meanindex15.6%vs64.9%);ahighKi67indexisinconclusiveMolecularanalysisIggenerearrangementbySouthernblotorPCR(NotethatPCRmayhavefalsenegativeresults)DetectionofBCL2generearrangementbySouthernblot,PCRorFISH,106,Kappa,Lambda,107,FL1:Ki67,RFH:Ki67,108,FL3:Ki67,109,套细胞淋巴瘤Mantlecelllymphoma:morphology,Diffuse,vaguelynodular,ormantlezonepatternBroadcytologicspectrumClassictype:smalllymphoidcellswithirregulartoroundnucleiBlastoidvariant(lymphoblasts,butTdT-)PleomorphicvariantOftenwithsolitaryepithelioidhistiocytesInterspersednakednuclei(folliculardendriticcells)Genetics:Iggenerearrangementt(11,14)(q13;q32),110,GrowthpatternofMCL,111,112,113,114,Roundnuclei,115,Mantlecelllymphoma:biologicmarkers,Bmarker+,CD5+,CD10-,CD23-,IgM+,IgD+Keydefiningfeature:CyclinD1+duetot(11;14)(q13;q32)orcryptictranslocation,116,CyclinD1,117,粘膜相关淋巴组织Mucosa-AssociatedLymphoidTissue(MALT),SpecializedsecondarylymphoidcompartmentsofmucosaltissuesNatural,e.g.,Waldeyersring,smallintestine,lungAcquiredinautoimmunedisease/inflammatione.g.,thyroid,salivarygland,lacrimalgland,stomachSimilarorganizationaslymphnode:B-cellfollicles,T-cellzonesLymphoidcellsacquirehomingproperties,118,119,LOWGRADEBCELLMALTLYMPHOMA(extranodalmarginalzoneB-celllymphoma),Usuallylocalizedatpresentation(66-79%)RecurrenceatotherMALTsites(“homing”)Manycanbetreatedbylocoregionaltherapyoreradicationofantigen-stimulationsourceCompleteremissionrate=72%5-yearoverallsurvival=74%(Gastric:90%),120,HistologicfeaturesoflowgradeMALTlymphoma,Small/medium-sizedcells(lymphocytes,centrocyte-like,monocytoidBcells)Patterns:diffuse,interfollicular,marginalzoneLymphoepitheliallesionsPlasmacellsarecommonReactivelymphoidfollicles+/-colonization,121,122,123,124,LowgradeMALTlymphoma:Immunophenotype,Aneoplasmofpost-germinalcenterBcellsPanB+,CD10-,CD5-,CyclinD1-,CD23-Keyfeatures:siteofinvolvementlymphoepitheliallesionexclusionofotherlowgradeB-celllymphomas,125,AfterHelicobactereradicationtherapy,126,弥漫性大B细胞淋巴瘤DIFFUSELARGEBCELLLYMPHOMA(DLBCL),CommonestnodalB-celllymphomaAheterogeneousentityFinalcommonpathwayforhighgradetransformationoflowgradeB-celllymphomas,127,Centroblastic/Immunoblastic,128,129,Multilobated,Pleomorphic,130,BURKITTLYMPHOMA,Threedifferentforms:Endemic(EquatorialAfrica;strongassociationwithEBV90%;commonlyaffectingjaws,gonads,kidneys)Sporadic(EBVassociationonly15%;commonlyinvolvingterminalileumandWaldeyersring)AIDS-related(EBVassociation30%;commonlyinvolvinglymphonodeandbonemarrow)AfricancasescanalsobeAIDS-related!,131,Burkittlymphoma,t(8;14)(q24;q32)orvariants,withtranslocationbetweenc-mycandIggeneMostlyadiseaseofyoungpatientsHighlyaggressive,butpotentiallycurablebychemotherapy,132,133,134,Burkittlymphoma:Immunogenetics,ProbablycorrespondstoIgM+blastsingerminalcenterPan-B+,CD10+,Bcl-6+,Bcl-2-Keyfeatures:C-MYCtranslocationmedium-sizedcellshighKi67index:100%germinalcentercellphenotype,135,CD20,CD10,136,Ki67,137,外周T和NK细胞淋巴瘤PERIPHERALTANDNKCELLLYMPHOMAS,Uncommon;80%),149,ExtranodalNK/Tcelllymphoma:Pathology,Necrosis(apoptosis)commonAngioinvasioncommon(notinvariablyseen)Broadcytologicspectrum:small,medium-sizedorlargecells,ormixedMayhavemanyadmixedinflammatorycells,150,151,152,Small,Medium-sized,Large,Broadcytologicspectrum,153,ExtranodalNK/Tcelllymphoma:immunophenotype,CD2+.sCD3-,cCD3e+,CD56+Cytotoxicgranulesperforin,granzymeB,TIA-1positiveCD4,CD5,CD7,CD8:usuallynegativeKeyfeatures:CD56+,EBER+IfCD56-,requiresEBER+andcytotoxicgranules+fordiagnosis,154,SurfaceCD3,CytoplasmicCD3,CD56,Frozentissue,Paraffinsection,155,PERIPHERALTCELLLYMPHOMAUNSPECIFIED外周T细胞淋巴瘤,非特殊型,AwastebasketcategoryVariableclinicalmanifestationsUsuallyhighstagedisease(nodal/extranodal)MayhaveeosinophiliaAggressive;relapsecommonTheextranodalcasesoftenexpressacytotoxiccellphenotype,156,PeripheralT-celllymphoma:Morphologiccluesforrecognition,PredominantparacorticalinvolvementProminenthighendothelialvenulesSpectrumofcellssizesandshapesIrregularnuclearcontoursClearcellsManyadmixedepithelioidhistiocytesandeosinophils,ButimmunostainingessentialforconfirmingTlineage,157,158,159,ANAPLASTICLARGECELLLYMPHOMA,primarysystemicform间变性大细胞淋巴瘤,原发系统性,TendstooccurinchildrenandyoungadultsNodalorextranodalpresentation(whichmayincludeskin,softtissue,bone,G.I.tract)Immunophenotype:CD30+;EMAusually+T-lineagemarkers+/-(Tornullcell)AproportionofcasesexpressALKduetotranslocationinvolvingALKgene,160,Hallmarkcells,161,ALKtranslocation(orexpression)hashelpedtodefineahomogeneoussubgroupofALCLThiscanbeeasilydetectedbyimmunostainingforALK-permittingre-definitionofthemorphologicspectrumofALCL:ClassicaltypeMonomorphicSmallcellLymphohistiocyticHypocellular,162,163,CD30,164,OverallsurvivalPrimarysystemicformofALCL,0,5,10,Years,ALCL,ALK+*,100%,50%,ALCL,ALK-,165,霍奇金淋巴瘤HODGKINLYMPHOMA,166,Lymphocytepredominance,Mixedcellularity,Nodularsclerosis,Lymphocytedepletion,NodularlymphocytepredominantHodgkinlymphoma(N-LPHL),RYECLASSIFICATION,WHOCLASSIFICATION,167,5,10,Years,Overallsurvival,N-LPHLdefinedbyimmunohistochemistry,cHLdefinedbyimmunohistochemistry,p=0.0071,168,Alymphomacharacterizedby:presenceofReed-Sternbergcellsandtheirvariantsconfirmedbymmunohistochemistryinanappropriatereactivecellularenvironment,169,Reed-Sternbergcellsandvariants,DiagnosticReed-SternbergcellsMononuclearHodgkincellLacunarcellL&HcellPleomorphicReed-SternbergcellKi67+100%,NoneedtofinddiagnosticReed-SternbergcellsinrenderingadiagnosisofHodgkinlymphoma.Itsokayifcellsarelargeenough,withprominentnucleoliandcompatibleimmunophenotype.,170,Reed-Sternbergcellsandvariants,Smalllymphocytes,Nuclearsizeofmostneoplasticcellsusuallyexceeds3t

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论